We have a robust pipeline of investigational therapies with the potential to address the unmet needs of patients living with ADHD, pain, addiction and diseases of the central nervous system (CNS).
With a proven track record in drug development, manufacturing and commercialization, we employ our industry-leading capabilities and proprietary technologies to uniquely solve some of the most intractable therapeutic challenges in these diseases and conditions.
Digital Health Pipeline
Device: First-in-Class, AI-Enhanced Digital ADHD Diagnostic
Therapeutic Area: ADHD
Stage: Preclinical